Corneal Crosslinking
For corneal conditions, trust experienced patient-centered eye care. Protect your cornea from injury.
- FDA-approved to treat mild to moderate keratoconus
- A 90-minute outpatient procedure
- Can increase corneal strength and rigidity by 3X or more
Am I a Candidate for Corneal Crosslinking?
CXL is newly FDA-approved in the US to treat individuals with mild to moderate keratoconus who meet other eligibility requirements, confirmed through a corneal evaluation.
What Is Corneal Crosslinking?
The cornea is the outermost layer of the eye, the clear dome that covers the front of the eye, responsible for as much as 75% of the eye’s focusing power, and made up of five separate layers each with an important function. With corneal crosslinking (CXL), our ophthalmologists apply specialized drops to the cornea, then shine ultraviolet light onto the cornea. This creates a chemical reaction that increases the number of links between fibers of corneal tissue, effectively slowing or stopping the progression of tissue degeneration. It’s a 90-minute outpatient procedure. While CXL doesn’t reverse damage that has already occurred, it allows intervention in disease progression early and can reduce or eliminate the need for corneal transplants in the future.
Patient Reviews
Corneal Crosslinking vs. Corneal Transplant
Corneal Crosslinking (CXL)
Strengthens your own cornea
- A 90-minute outpatient procedure using UV light and specialized drops
- Can increase corneal strength and rigidity by 3X or more
- Slows or stops the progression of keratoconus
- Does not reverse damage that has already occurred
Corneal Transplant
Replaces damaged corneal tissue
- A damaged or diseased cornea is replaced with a healthy donor cornea
- May be needed if keratoconus progresses beyond what CXL can address
- A more involved surgical procedure than CXL
Your ophthalmologist will determine whether CXL, a transplant, or another approach fits your stage of keratoconus.
Your Corneal Crosslinking Journey
- Corneal shape and thickness measured
- Keratoconus severity assessed
- Candidacy for CXL confirmed
- Specialized drops applied to the cornea
- Ultraviolet light equipment prepared
- Questions about the 90-minute procedure answered
- Ultraviolet light shone onto the cornea
- Chemical reaction increases fiber links in corneal tissue
- Outpatient procedure completed same day
- Healing monitored at follow-up visits
- Corneal strength and shape tracked over time
- Disease progression slowed or stopped
Expected Corneal Crosslinking Outcomes & Recovery
What Patients Can Expect in the First 30 Days
- Specialized drops and ultraviolet light are used during the 90-minute procedure
- Healing and corneal strength are monitored at follow-up visits
- CXL does not reverse existing damage but can slow or stop further progression
- Corneal shape and thickness are tracked over time
Safety & Risk Considerations
Safety Profile
- CXL can increase the cornea's strength and rigidity by 3X or more
- Evergreen Eye Center has increased corneal tissue strength successfully in 90% of cases
- CXL is a 90-minute outpatient procedure
Possible Side Effects
- CXL does not reverse damage that has already occurred to the cornea, it is intended to slow or stop further progression
- The 90-minute procedure involves specialized drops and ultraviolet light exposure to the cornea
- Your doctor will review what to expect during healing and monitor your cornea's strength and shape at follow-up visits
How We Minimize Risk
FDA-Approved Protocol
CXL is FDA-approved to treat individuals with mild to moderate keratoconus who meet eligibility requirements.
Early Intervention
While CXL doesn't reverse existing damage, treating early can reduce or eliminate the need for a future corneal transplant.
Experienced, Dedicated Ophthalmologists
Evergreen Eye Center became the only crosslinking FDA clinical trials center in Washington in 2014.
Corneal Crosslinking: Why Choose Evergreen Eye Center
Our Corneal Crosslinking Specialist
Corneal Crosslinking in Seattle
Cost & Insurance
Insurance We Accept
28+ plans accepted
- Accepted plans include Aetna, Blue Cross Blue Shield, Cigna, Kaiser Foundation Health Plan, Medicare, Premera Blue Cross, Regence, TriWest/Tricare, and United Healthcare, among 28+ carriers
- Different carriers and plans have different requirements, so coverage can vary
- Contact your insurance provider directly to confirm your specific benefits
Coverage requirements vary by carrier and plan, contact your insurer to confirm your specific benefits.
Payment & Financing Options
Ways to pay for your care
- Cash, check, and major credit cards (Visa, MasterCard, American Express, Discover) are accepted
- Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA) can be used
- Limited CareCredit financing is available for qualifying procedures of $200 or more, subject to credit approval
Our billing team can answer payment questions at 800-340-3595.
Flexible financing available. We work with CareCredit to offer low- and no-interest payment plans for premium lens upgrades and elective procedures. Ask about your options at your consultation.
locationsFrequently Asked Questions
What is a corneal transplant?
In corneal transplant surgery, a damaged or diseased cornea is replaced with a healthy donor cornea.


